Loading clinical trials...
Loading clinical trials...
A Randomized Parallel-Group Study to Evaluate the Efficacy and Tolerability of Two Dosing Regimens of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Conditions
Interventions
CTP-543
CTP-543 Matching Placebo
Locations
10
United States
Investigative Site
Irvine, California, United States
Investigative Site
San Francisco, California, United States
Investigative Site
New Haven, Connecticut, United States
Investigative Site
Boynton Beach, Florida, United States
Investigative Site
Boston, Massachusetts, United States
Investigative Site
Boston, Massachusetts, United States
Start Date
March 21, 2019
Primary Completion Date
November 21, 2019
Completion Date
November 21, 2019
Last Updated
December 9, 2022
NCT06826196
NCT06562270
NCT07133308
NCT06327581
NCT07023302
NCT07152119
Lead Sponsor
Concert Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions